---
schema_version: "secwatch.filing_event.v1"
accession: "0001021771-23-000057"
form_type: "8-K"
ticker: "BRTX"
cik: "0001505497"
company_name: "BioRestorative Therapies, Inc."
filed_at: "2023-07-13T23:59:59+00:00"
generated_at: "2026-06-13T08:42:23.994864+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BRTX prices $2.1M registered direct offering of 685,033 shares at $3.03/share

## Summary
- Offering of 685,033 shares at $3.03/share for gross proceeds of approximately $2.1M; closing expected July 13, 2023.
- Net proceeds to fund BRTX-100 clinical trials, ThermoStem Program R&D, and general corporate purposes.
- Titan Partners Group acting as sole placement agent with 6% cash fee and up to $60K expense reimbursement.
- Shares offered under effective S-3 shelf registration (File No. 333-269631).

## SEC filing metadata
- accession: 0001021771-23-000057
- form_type: 8-K
- ticker: BRTX
- cik: 0001505497
- company_name: BioRestorative Therapies, Inc.
- filed_at: 2023-07-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1505497/000102177123000057/0001021771-23-000057-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1505497/000102177123000057/form8kdtd07112023.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001021771-23-000057
- JSON: https://secwatch.observer/filing/0001021771-23-000057.json
- Plain text: https://secwatch.observer/filing/0001021771-23-000057.txt

## Key facts
- Material Agreements
  BioRestorative Therapies, Inc. entered into Placement Agency Agreement with Titan Partners Group LLC, a division of American Capital Partners, LLC (effective 2023-07-11).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Titan Partners Group LLC, a division of American Capital Partners, LLC
  - Effective: 2023-07-11
  source text: the Company entered into a placement agency agreement dated July 11, 2023 (the “Placement Agency Agreement”), with Titan Partners Group LLC, a division of American Capital Partners, LLC
  evidence_url: https://www.sec.gov/Archives/edgar/data/1505497/000102177123000057/0001021771-23-000057-index.htm
- Material Agreements
  BioRestorative Therapies, Inc. entered into Purchase Agreement with several institutional buyers and accredited investors valued at approximately $2.1 million (effective 2023-07-11).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: several institutional buyers and accredited investors
  - Value: approximately $2.1 million
  - Effective: 2023-07-11
  source text: On July 11, 2023, BioRestorative Therapies, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with several institutional buyers and accredited investors (the “Purchasers”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1505497/000102177123000057/0001021771-23-000057-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.